Business Context and Reporting Period
Hyliion Holdings Corp. filed a Form 8-K dated December 2, 2020, reporting employment agreements entered into with Chief Executive Officer Thomas Healy and Chief Technology Officer Patrick Sexton. The agreements were retroactively effective October 1, 2020, the date of the company’s initial business combination with Hyliion Inc.
Key Financial and Compensation Terms
| Executive | Base Salary | Initial Term | Equity Awards |
|---|---|---|---|
| Thomas Healy, CEO | $650,000 annually | Three years, ending October 1, 2023; automatic one-year renewals unless timely notice is provided | Eligible for annual time-based RSUs and a one-time performance-based RSU award for 1,500,000 shares |
| Patrick Sexton, CTO | $450,000 annually | Three years, ending October 1, 2023; automatic one-year renewals unless timely notice is provided | Initial annual time-based RSU award for 125,000 shares, subsequent annual awards with a target grant-date value of $1,250,000, and a one-time performance-based RSU award for 500,000 shares |
Both executives are eligible for discretionary cash bonuses. The performance-based awards are expected to be granted in December 2020 and are subject to objective performance criteria covering October 1, 2020 through December 31, 2025. The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-financial metrics for the reporting period.
Material Changes Versus the Prior Comparable Period
The filing reports new or formalized post-business-combination employment agreements for the CEO and CTO. It does not provide comparative operating or financial results.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Severance provisions may apply if either executive’s employment is not renewed, is terminated without cause, or is terminated by the executive for good reason.
- Mr. Healy’s potential severance includes 36 months of base-salary continuation, certain accelerated equity vesting, extended option exercisability, and health-benefit reimbursement for up to 18 months.
- Mr. Sexton’s potential severance includes 12 months of base-salary continuation, certain accelerated equity vesting, extended option exercisability, and health-benefit reimbursement for up to 12 months.
- Specified equity awards may accelerate upon death or a change in control, subject to the agreement terms and applicable performance criteria.
- The agreements contain confidentiality, non-competition, non-solicitation, intellectual-property, and release-of-claims conditions relevant to certain severance benefits.
- Annual time-based RSUs generally vest over four years. Performance-based awards may vest immediately before a change in control based on actual achievement of the applicable criteria.
Important Facts to Verify
- Review Exhibits 10.1 and 10.2 for the complete employment-agreement terms, definitions, and termination provisions.
- Confirm the actual grant dates, share amounts, performance criteria, and accounting expense for the contemplated RSU awards.
- Assess the potential dilution and change-in-control consequences of the 2,000,000 aggregate performance-based RSUs and other annual equity awards.
- Verify future disclosures regarding executive compensation, severance obligations, equity awards, and related stock-based compensation expense.